Co-Diagnostics Sets Court-Ordered Meeting to Approve Up-to-1-for-750 Reverse Split, Astor Note Conversion and Warrant Exercise
CODX is trading near its 52-week low of $0.63 (6.8% above the low) on light trading volume (0.1× avg).
Summary
Co-Diagnostics scheduled a court-ordered special meeting after four failed quorum attempts, asking holders to approve a reverse split of up to 1-for-750, conversion of the J.J. Astor secured notes, exercise of 3.4M warrants at $1.56, and a permanent one-third quorum.
Key Events · Corporate Governance and Compliance · CODX
-
Court-Ordered Meeting, One-Third Quorum
A Utah court order entered October 15, 2026 (Egan v. Co-Diagnostics, Case No. 260200106) sets a 33 1/3% quorum for this special meeting only, after the 2026 annual meeting drew just 2,179,921 of 5,278,957 shares (~41.29%) as of September 28, 2026.
-
Reverse Split Range Expanded to 1-for-750
Proposal 8 authorizes one or more reverse splits at not less than 1-for-2 with a cumulative effect up to 1-for-750, at Board discretion within 12 months — wider than the up-to-1-for-50 request in the September 21 preliminary proxy. At the October 13, 2026 close of $0.7645, a 1-for-750 split implies about $573 per share.
-
Astor Note Conversion Approval Sought
Proposal 7 covers conversion of the October 9, 2026 J.J. Astor notes: $2.1M funded against a $2.835M original principal (35% OID), plus an optional $1.0M tranche, 600,000 commitment shares, conversion at 90% of the 10-day low VWAP with a $0.218 floor that resets every six months.
-
Warrant Exercise Worth Up to $5.31M
Proposal 6 seeks Nasdaq 5635(d) approval to exercise 3,404,724 new warrants at $1.56, issued August 3, 2026 in the inducement that raised $2.67M. Full cash exercise would bring in about $5.31M; failure to approve forces a shareholder meeting every 90 days.
Analysis · CODX · Industrial Applications And Services
This proxy is the company's last procedural lever. Four attempts to hold an annual meeting failed for lack of a majority quorum, so the CEO petitioned a Utah court and got a one-third quorum for a court-ordered special meeting. On the ballot: a reverse split now authorized up to a cumulative 1-for-750 (versus the 1-for-50 previously sought), approval to convert the J.J. Astor secured notes that already pledge 100% of ATM proceeds to the lender, and approval to let 3.4 million new warrants at $1.56 be exercised for up to roughly $5.31M. If shareholders vote no on the warrant proposal, the company must reconvene every 90 days until approval — real cost for a company that reported a going-concern warning and $3.6M of cash in its last 10-Q. The Astor conversion approval is the most consequential item: the notes convert at 90% of the 10-day low VWAP with a floor that resets every six months, so a lower floor means materially more shares. The filing itself concedes that if the floor fell to $0.001, the share count issuable under the note would be effectively uncapped.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 37.9% of the 895 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.87%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CODX was trading at $0.67 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $5M. The 52-week trading range was $0.63 to $46.50. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.